Large Joint Devices Market Size, Share, and Trends Analysis | Global | 2024-2030 | MedSuite | Includes: Knee Replacement Market, Hip Replacement Market, and 1 more
In 2023, the global orthopedic large joint device market was valued at over $20.5 billion. It is anticipated to grow at a compound annual growth rate (CAGR) of 3.3% during the forecast period, reaching over $25.7 billion.
The comprehensive report on the global orthopedic large joint devices market includes knee reconstruction devices, hip reconstruction devices, and bone cement. Key players in this market are Zimmer Biomet, Stryker, and DePuy Synthes.
MARKET REPORT DATA TYPES INCLUDEDUnit Sales, Average Selling Prices, Market Value & Growth Trends
Forecasts Until 2030, and Historical Data to 2020
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Procedure Volumes
Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Large Joints Market TrendsIn the orthopedic large joint device market, there is a growing trend towards automating replacement procedures. Companies are increasingly exploring robotic systems to assist with implanting devices worldwide. This shift aims to make procedures less invasive, which could shorten recovery times and reduce the duration of surgeries.
Global Large Joints Market Share InsightsZimmer Biomet led the global orthopedic large joint device market in 2023. The company's dominance is attributed to its Persona® The Personalized Knee System and Oxford® Partial Knee for knee reconstruction, as well as its strong performance in the hip reconstruction segment with the Taperloc® Hip System, Arcos® Modular Hip System, G7® Acetabular System, and Continuum™ Acetabular System. Continued investment in these devices is expected to maintain Zimmer Biomet's leadership in the coming years.
Stryker was the second-leading competitor in 2023, particularly strong in the global bone cement market with its Simplex P™ brand. Its hip portfolio includes total hip arthroplasty solutions for both primary and revision procedures, as well as the Mako™ Total Hip Replacement. Ongoing product development is anticipated to support Stryker’s continued market presence.
DePuy Synthes ranked third, bolstering its portfolio with Attune® Knee revision options, the Attune® Revision Fixed Bearing Tibial Base, and Cemented Stem for primary and revision surgeries. Despite strong competition, DePuy Synthes is expected to sustain its market position through ongoing product innovation.
MARKET SEGMENTATION SUMMARYYou can view all these included reports and segmentation here:
Hip Replacement Market – MedCore – Includes:
Total knee replacement, partial knee replacement and knee replacement revision devices.
Knee Replacement Market – MedCore – Includes:
Total hip replacement, partial hip replacement and hip replacement revision.
Bone Cement Market – MedCore – Includes:
Traditional bone cement and premixed antibiotic bone cement.